Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck;Aplicaciones clínicas del diagnóstico de las alteraciones de p53 en el carcinoma escamoso de cabeza y cuello (p53 en el CECC)

Medicina Oral

Volumn 7, Issue 2, 2002, Pages 108-120

  Lopez Martinez M ^a   Anzola, M ^a   Cuevas, N ^a   Aguirre, J M ^a   Martínez de Pancorbo, Marian ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Human papillomavirus (HPV); Mutation; p53; Squamous cell carcinoma of the head and neck

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; GENE MUTATION; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; PATHOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PROGNOSIS;

EID: 0036123176     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Tumor suppressor gene
2. Molecular origins of human cancer
3. Clinical implications of the p53 tumor suppressor gene
4. The p53 tumour suppressor gene
5. P53 mutations in human cancers
6. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis
7. Tumorigenesis associated with the p53 tumor suppressor gene
8. The 1993 Walter Hubert lecture: The role of the p53 tumor suppressor gene in tumorigenesis
9. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
10. Frequent p53 mutations in head and neck cancer
11. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis
12. P53 protein expression in malignant, pre-malignant and non-malignant lesions of the lip
13. P53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma
14. Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapy
15. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users
16. P53 mutations in human cancers
17. Occurrence of p53 gene deletions and human papillomavirus infection in human head and neck cancer
18. The origins of multiple squamous cell carcinomas in the aerodigestive tract
19. P53 and human cancers
20. Tumor suppressor genes and human cancer
21. Implicaciones de los oncogenes en el cáncer de colon
22. P53 mutations in lung cancers from non-smoking and atomic bomb survivors
23. The 1995 Walter Hubert Lecture-molecular epidemiology of human cancer: Insights from the mutational analysis of the p53 tumor-suppressor gene
24. P53 tumor suppressor gene: From the basic research laboratory to the clinic an abridged historical perspective
25. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
26. Expression of the tumour suppressor gene p53 in oral cancer
27. Cytoplasmatic expression of p53 protein and its morphological features in salivary gland lesions
28. Cytoplasmatic p53 is associated with ribosomes
29. Expression of p53 mutant nuclear phophoprotein in oral carcinoma and potentially malignant oral lesions
30. Precise epitope mapping of the murine transformation-associated protein, p53
31. Expression of p53 in premalignant and malignant squamous epithelium
32. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro
33. P53: From inductive signal to cellular effect
34. Correlation between the conformational phenotype of p53 and its subcellular location
35. P53-HSP70 complexes in oral dysplasia and cancer: Potential prognostic implications
36. P53 mutations, ras mutations, and p53 heat shock 70 protein complexes in human lung carcinoma cell lines
37. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
38. Amplification of a gene encoding a p53 associated protein in human sarcomas
39. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia
40. Differential induction of transcriptionally active p53 following UV or ionizing radiation, defects in chromosome instability syndromes?
41. P53 inmunohsitochemistry: A word of caution
42. P53 in tumor pathology: Can we trust immunohistochemistry? Revisted!
43. Incresed expresion of mutant forms of p53 oncogene in primary lung cancer
44. Analysis of p53 expression in human tumors: An antibody raised against human p53 expressed in E. Coli
45. An evaluation of six antibodies for inmunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
46. Multifactorial analysis of p53 alteration in human cancer: A review
47. Nucleic acid- based methods for the detection of cancer
48. Clinical applications of the p53 tumor suppressor gene
49. Light-generated oligonucleotide arrays for rapid DNA sequence analysis
50. Rapid p53 sequence analysis in primary cancer using an oligonucleotide probe array
51. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
52. Role of p53 polymorphism in the development of human papilomavirus-associated cancer
53. Role of a p53 polymorphism in the development of human papillomavirus associated cancer
54. EBNA-5 an Epstein Barr virus encoded nuclear antigen, binds to the retinoblastoma and p53 proteins
55. Association of human papillomavirus types 16 and 18 E6 proteins with p53
56. P53 in SV40-transformed DNA-damaged human cells binds to its cognate sequence but fails to transactivate target genes
57. P53 function and dysfunction
58. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes
59. Simian virus 40 and human cancer
60. Molecular assesment of histopathological staging in squamous cell carcinoma of head and neck
61. P53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
62. Unknown primary head and neck squamous cell carcinoma: Molecular identification of the site of origin
63. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis
64. The incidence of p53 mutations increases with progression of head and neck cancer
65. Proliferative activity and loss of function of tumour suppressor genes as "biomarkers" in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma
66. Expression of p53 protein correlates with decresed survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan
67. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas
68. P53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma
69. Predicting Cancer Development in Oral Leukoplakia: Ten years of translational research
70. Lack of molecular markers to predict malignant potential of oral precancer
71. Expression of mutated p53 occurs in tumor distant epithelia of head and neck cancer patients: A possible molecular basis for development of multiple tumours
72. Discordant p53 mutations in primary head and neck cancer and corresponding second primary cancers of the upper aerodigestive tract
73. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease
74. Radioimmunoassay for nanogram quanties of DNA
75. Microsatellite alterations in plasma DNA of head and neck cancer patients
76. Prognostic significance of p53 overexpression in node-negative breast carcinoma: Preliminary studies support cautious optimism
77. Histological effects and predictive biomarkers of TPP induction chemotherapy for oral carcinoma
78. P53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck
79. Role of the p53 tumor suppressor gene in cell cycle arrest and radio-sensitivity of Burkitt's lymphoma cell lines
80. Suppression of human colorectal carcinoma cell growth by wild- type p53
81. Growth suppression of human breast cancer by the introduction of a wild- type p53 gene
82. Gene therapy of cancer through restoration of tumor suppressor functions?
83. Wild- type p53 induce apoptosis of myeloid leukemic cells that inhibited by interleukin-6
84. Induction of apoptosis of wild-type p53 in a human colon tumor derived cell line
85. A retroviral wild- type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis
86. Growth suppression of human head and neck cancer cells by the introduction of a wild- type p53 gene via recombinant adenovirus
87. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus mediated transfer of the wild-type p53 gene
88. P53- mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy
89. Adenoviral mediated wild- type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation